These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31820975)

  • 21. Exploring the interactional details between aldose reductase (AKR1B1) and 3-Mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid through molecular dynamics simulations.
    Zhan JY; Ma K; Zheng QC; Yang GH; Zhang HX
    J Biomol Struct Dyn; 2019 Apr; 37(7):1724-1735. PubMed ID: 29671687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
    Elmazoglu Z; Prnova MS; Stefek M; Ceylan AF; Aschner M; Rangel-López E; Santamaria A; Karasu C
    Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly selective aldose reductase inhibitors. II. Optimization of the aryl part of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Kotani T; Ishii A; Nagaki Y; Toyomaki Y; Yago H; Suehiro S; Okukado N; Okamoto K
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):297-304. PubMed ID: 9118444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and α-glycosidase and molecular docking studies.
    Demir Y; Taslimi P; Koçyiğit ÜM; Akkuş M; Özaslan MS; Duran HE; Budak Y; Tüzün B; Gürdere MB; Ceylan M; Taysi S; Gülçin İ; Beydemir Ş
    Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000118. PubMed ID: 32761859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design synthesis and evaluation of novel aldose reductase inhibitors: The case of indolyl-sulfonyl-phenols.
    Koutsopoulos K; Lavrentaki V; Antoniou I; Kousaxidis A; Lefkopoulou M; Tsantili-Kakoulidou A; Kovacikova L; Stefek M; Nicolaou I
    Bioorg Med Chem; 2020 Aug; 28(15):115575. PubMed ID: 32631572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
    Bhadada SV; Vyas VK; Goyal RK
    Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats.
    Soltesova Prnova M; Ballekova J; Gajdosikova A; Gajdosik A; Stefek M
    Physiol Res; 2015; 64(4):587-91. PubMed ID: 26291727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does inhibition of aldose reductase contribute to the anti-inflammatory action of setipiprant?
    Ballekova J; Soltesova-Prnova M; Majekova M; Stefek M
    Physiol Res; 2017 Sep; 66(4):687-693. PubMed ID: 28406694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldose reductase inhibitory effect by tectorigenin derivatives from Viola hondoensis.
    Moon HI; Jung JC; Lee J
    Bioorg Med Chem; 2006 Nov; 14(22):7592-4. PubMed ID: 16870454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Kotani T; Nagaki Y; Ishii A; Konishi Y; Yago H; Suehiro S; Okukado N; Okamoto K
    J Med Chem; 1997 Feb; 40(5):684-94. PubMed ID: 9057855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase.
    Crespo I; Giménez-Dejoz J; Porté S; Cousido-Siah A; Mitschler A; Podjarny A; Pratsinis H; Kletsas D; Parés X; Ruiz FX; Metwally K; Farrés J
    Eur J Med Chem; 2018 May; 152():160-174. PubMed ID: 29705708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis.
    Iwata Y; Arisawa M; Hamada R; Kita Y; Mizutani MY; Tomioka N; Itai A; Miyamoto S
    J Med Chem; 2001 May; 44(11):1718-28. PubMed ID: 11356107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
    Imran A; Tariq Shehzad M; Al Adhami T; Miraz Rahman K; Hussain D; Alharthy RD; Shafiq Z; Iqbal J
    Bioorg Chem; 2021 Oct; 115():105164. PubMed ID: 34314916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly selective aldose reductase inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Ishii A; Kotani T; Nagaki Y; Shibayama Y; Toyomaki Y; Okukado N; Ienaga K; Okamoto K
    J Med Chem; 1996 Apr; 39(9):1924-7. PubMed ID: 8627616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B
    Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose.
    Elmazoglu Z; Prnova MS; Santamaria A; Stefek M; Karasu C
    Neurotox Res; 2021 Apr; 39(2):210-226. PubMed ID: 33146867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors.
    Jung HA; Moon HE; Oh SH; Kim BW; Sohn HS; Choi JS
    Chem Biol Interact; 2012 May; 197(2-3):110-8. PubMed ID: 22543015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10.
    Ruiz FX; Cousido-Siah A; Porté S; Domínguez M; Crespo I; Rechlin C; Mitschler A; de Lera ÁR; Martín MJ; de la Fuente JÁ; Klebe G; Parés X; Farrés J; Podjarny A
    ChemMedChem; 2015 Dec; 10(12):1989-2003. PubMed ID: 26549844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S; Parveen S; Hao X; Zhang S; Wang W; Qin X; Yang Y; Chen X; Zhu S; Zhu C; Ma B
    Eur J Med Chem; 2014 Jun; 80():383-92. PubMed ID: 24793885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.